Steven Cohen's position in Myriad Genetics is currently worth $1.36 Million. That's 0.00% of their equity portfolio (729th largest holding). The first Myriad Genetics trade was made in Q4 2014. Since then Steven Cohen bought shares sixteen more times and sold shares on fifteen occasions. The investor's estimated purchase price is $7.91 Million, resulting in a loss of 83%.